Pfizer Inc.(PFE)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
PFE | 171.62 B | 39.62x | 2.60% | 6.80% | $0.76 | 5.01% | 0.74x | 5.71% | $30.25 | $23.62 |
LLY | 1.14 T | 43.09x | 47.70% | 33.53% | $29.79 | 102.29% | 1.62x | 0.50% | $1311.75 | $788.84 |
JNJ | 625.03 B | 39.36x | 5.90% | 16.20% | $6.59 | - | 0.58x | 0.50% | $281.07 | $180.59 |
ABBV | 510.84 B | 81.66x | 10.20% | 9.80% | $3.54 | - | - | 2.36% | $291.40 | $188.25 |
AZN | 261.82 B | 25.23x | 6.40% | 17.02% | $6.69 | 21.97% | 0.64x | 1.91% | $210.52 | $153.41 |
NVO | 131.36 B | 9.62x | 2.10% | 35.35% | $4.09 | 59.82% | 0.63x | 29.73% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Pfizer Inc. (PFE) compared to its primary competitors (including LLY, JNJ, ABBV) reveals distinct metrics. PFE trades roughly in line with its competitors, with a P/E ratio of 39.6x versus the peer average of 40.4x, reflecting valuation parity within the industry. In terms of growth, PFE's revenue growth of 2.6% lags behind the peer average of 12.6%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 6.8% is below the peer average of 20.0%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• PFE ranks #3 in P/E ratio, #5 in revenue growth, and #5 in profit margins
• Average ranking: #4 - ⚠️ Room for improvement relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $29.67 | $30.25 | $29.59 | $30.11 | 34,241,703 | +2.28% |
| 2026-10-19 | $29.31 | $29.69 | $29.25 | $29.44 | 20,808,300 | -0.47% |
| 2026-10-16 | $29.72 | $29.74 | $29.42 | $29.58 | 28,627,500 | +0.48% |
| 2026-10-15 | $29.57 | $29.88 | $29.42 | $29.44 | 32,891,000 | +0.79% |
| 2026-10-14 | $28.60 | $29.49 | $28.55 | $29.21 | 39,370,500 | +2.96% |
| 2026-10-13 | $28.61 | $28.61 | $28.13 | $28.37 | 26,837,200 | -0.11% |
| 2026-10-12 | $28.42 | $28.50 | $28.28 | $28.40 | 18,555,600 | +0.42% |
| 2026-10-09 | $27.61 | $28.29 | $27.59 | $28.28 | 23,204,100 | +1.65% |
| 2026-10-08 | $27.90 | $28.00 | $27.48 | $27.82 | 44,433,400 | -0.64% |
| 2026-10-07 | $27.62 | $28.17 | $27.55 | $28.00 | 31,230,400 | +1.82% |
| 2026-10-06 | $27.48 | $27.71 | $27.20 | $27.50 | 24,066,100 | +0.33% |
| 2026-10-05 | $27.65 | $27.72 | $27.12 | $27.41 | 33,005,400 | -1.40% |
| 2026-10-02 | $28.15 | $28.16 | $27.44 | $27.80 | 35,007,900 | -1.14% |
| 2026-10-01 | $28.45 | $28.59 | $28.08 | $28.12 | 30,494,200 | -1.40% |
| 2026-09-30 | $28.79 | $28.95 | $28.52 | $28.52 | 33,629,100 | -0.70% |
Explore More Analysis for PFE
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.